Company / Operating Cash Flow
LIFECORE BIOMEDICAL, INC. \DE\ Operating Cash Flow History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$29.8M
FY2019
5-year range
$20.8M / $29.8M
FY2015-FY2019
Trend
+43.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 8 years, ranging from $7M in FY2012 to $30M in FY2019.
Based on SEC 10-K filings.
$30M in FY2019 with a 5-year CAGR of +6.1%.
Improved from $27M to $30M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +6.1%, indicating consistent growth.
- In FY2019, operating cash flow increased 43.7% year-over-year.
- Lowest operating cash flow in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $29.8M | +43.7% |
| FY2018 | $20.8M | -22.0% |
| FY2017 | $26.6M | +26.5% |
| FY2016 | $21.0M | -0.9% |
| FY2015 | $21.2M | -4.3% |
| FY2014 | $22.2M | +53.3% |
| FY2013 | $14.5M | +93.4% |
| FY2012 | $7.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026